4-Methyl-N-(phenylethynyl)-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide

Catalog No. :
ACLWXV482
CAS No. :
2170120-07-5
Molecular Formula :
C20H21NO3S
Molecular Weight :
355.46

IUPAC Name:4-methyl-N-(phenylethynyl)-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide

4-Methyl-N-(phenylethynyl)-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methyl-N-(phenylethynyl)-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide
IUPAC Name4-methyl-N-(phenylethynyl)-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide
Molecular FormulaC20H21NO3S
Molecular Weight355.46
SMILESO=S(C1=CC=C(C)C=C1)(N(C#CC2=CC=CC=C2)CC3OCCC3)=O
InChI KeyXGMYABXHAMNAAL-UHFFFAOYSA-N
SynonymBenzenesulfonamide, 4-methyl-N-(2-phenylethynyl)-N-[(tetrahydro-2-furanyl)methyl]-;4-Methyl-N-(phenylethynyl)-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide
CAS No.2170120-07-5
PubChem CID154730327

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLWXV482 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCPZB630 route compound structure diagram
    ACCPZB630591-50-4 In Stock
  4. Then
  5. ACLWXV482 route product structure diagram
    ACLWXV4822170120-07-5
Inquiry

2. ACLWXV482 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLWXV482 route product structure diagram
    ACLWXV4822170120-07-5
Inquiry

Comments (0)